Monogram Health Settles for $2.4 Million Over Medicare Advantage Fraud Allegations
Monogram Health has agreed to a $2.4 million settlement over allegations of submitting inaccurate diagnosis codes, thereby inflating payments from the Medicare Advantage program.
Monogram Health Professional Services PC and Monogram Health Inc. faced allegations under the False Claims Act for claiming incorrect diagnosis codes, creating unjust Medicare Advantage payments. This resolution emphasizes the U.S. Department of Justice's commitment to ensuring precise payment calculations in Medicare Advantage, thereby protecting taxpayer funds intended for public health initiatives.
The Role of Medicare Advantage in Health Care
The Medicare Advantage (MA) program allows beneficiaries to enroll in private plans managed by Medicare Advantage Organizations (MAOs). Under this system, the Centers for Medicare & Medicaid Services (CMS) provides MAOs monthly payments adjusted for risk using the Hierarchical Conditions Category (HCC) model. Providers report diagnoses that influence these risk scores, resulting in potentially higher payments for more severe conditions or expensive treatments.
Monogram Health's Alleged Misconduct
Between January 2021 and December 2023, Monogram Health was accused of knowingly submitting inaccurate diagnosis codes. The allegation involves codes submitted without valid documentation or clinical necessity, increasing risk scores and inflating CMS payments to MAOs. Monogram's practice of providing in-home care and entering risk-sharing contracts with MAOs gave them a financial motivation to enhance risk scores by reporting additional diagnosis codes.
Legal and Financial Implications
The settlement underscores a broader governmental effort to mitigate fraud within federal programs. It was facilitated by the Civil Division of the Justice Department, the U.S. Attorney’s Office for the Central District of California, and the Department of Health and Human Services Office of Inspector General. Dr. Ajay Gupta, a whistleblower and former Monogram employee, brought the allegations under the qui tam provisions of the False Claims Act and will receive approximately $380,000 as part of the settlement.
Government's Fraud Prevention Strategy
- Task Force to Eliminate Fraud: A focused government initiative to counteract fraud within federal programs.
- National Fraud Enforcement Division: Aims to protect public integrity by addressing fraudulent claims.
- Impact of Resolutions: Helps recover taxpayer funds and holds fraudulent entities accountable without proven liability from allegations.
This resolution highlights the ongoing collaborative focus on healthcare fraud, reinforcing the Justice Department’s endeavor to sustain both the financial and ethical integrity of taxpayer-funded health programs. The case resolution is a reminder that individuals can report potential healthcare fraud or abuse to the Department of Health and Human Services' hotline.